LeMaitre Vascular Ranked #48 of the 100 Best of Massachusetts Businesses
BURLINGTON, Mass., May 27, 2011 (GlobeNewswire via COMTEX) --
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, was ranked as #48 of the 100 Best of Massachusetts businesses by the Boston Globe. The Globe 100 ranks the best-performing publicly traded corporations based in Massachusetts.
"We are honored to receive this recognition," said George W. LeMaitre, Chairman and CEO. "This is a testament to the hard work and effort put forth by all employees that produced our solid 2010 results."
About The Boston Globe
The Boston Globe and Boston.com are wholly owned by The New York Times Company, a leading media company with 2010 revenues of $2.4 billion, which includes The New York Times, the International Herald Tribune, The Boston Globe, 15 other daily newspapers and more than 50 Web sites, including NYTimes.com, Boston.com and About.com. The Company's core purpose is to enhance society by creating, collecting and distributing high-quality news, information and entertainment.
About the Globe 100 ranking methodology
The Globe 100 ranks Massachusetts-based public companies based on financial data from the four quarters ending closest to December 31, 2010, and for corresponding quarters a year earlier. To be eligible, the company must be traded publicly for the entire 2010 calendar year on the New York Stock Exchange, the Nasdaq or the American Stock Exchange and report revenue and profit for both 2009 and 2010. Companies are ranked on four criteria: return on average equity, one-year percentage change in revenue, one-year percentage change in profit margin and 2010 revenue.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. We sell vascular devices and implants to address the needs of our core customer, the vascular surgeon. Our principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.
Forward-Looking Safe Harbor Statement
Certain statements set forth above that are not clearly historical in nature are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although LeMaitre Vascular believes that such statements are based on reasonable assumptions within the bounds of its knowledge, these forward-looking statements are neither promises nor guarantees. LeMaitre Vascular's business is subject to significant risks and uncertainties and there can be no assurance that its actual results will not differ materially from its expectations. These risks and uncertainties include, among others, the risk factors that are discussed in LeMaitre Vascular's Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. The forward-looking statements made in this release are made only as of the date hereof, and LeMaitre Vascular disclaims any intention or responsibility for updating predictions or expectations contained in this release.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: LeMaitre Vascular, Inc.
CONTACT: LeMaitre Vascular, Inc. Investor Relations Aaron Grossman +1-781-221-2266 http://www.lemaitre.com http://www.lemaitre.com/investor